Clinical trials
Terminated Phase 1/2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 2 |
| Therapeutic Advances in Childhood Leukemia Consortium | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Cellestia Biotech AG | 1 |
| Mundipharma Research Limited | 1 |
| National Cancer Institute (NCI) | 1 |
| Northwestern University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 9 |
| Burkitt Lymphoma | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Lymphoma, Non-Hodgkin | 3 |
| Recurrence | 3 |
| Hodgkin Disease | 2 |
| Immunoblastic Lymphadenopathy | 2 |
| Leukemia | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Lymphoma, B-Cell, Marginal Zone | 2 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.